2006 annual financial data
XTL Biopharmaceuticals 2006 Operating margin
XTL Biopharmaceuticals 2006 operating margin with verified reported values.
Direct answer
Operating margin was -3,534.36%.
Operating income was -16,046,000 USD and net income was -15,132,000 USD.
Operating cash flow was -12,587,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 454,000 USD
- Operating income
- -16,046,000 USD
- Net income
- -15,132,000 USD
- Operating cash flow
- -12,587,000 USD